A COMPARATIVE-STUDY ON EXPRESSION OF PROSTATIC INHIBIN PEPTIDE, PROSTATE ACID-PHOSPHATASE AND PROSTATE-SPECIFIC ANTIGEN IN ANDROGEN-INDEPENDENT HUMAN AND RAT PROSTATE CARCINOMA CELL-LINES
Sv. Garde et al., A COMPARATIVE-STUDY ON EXPRESSION OF PROSTATIC INHIBIN PEPTIDE, PROSTATE ACID-PHOSPHATASE AND PROSTATE-SPECIFIC ANTIGEN IN ANDROGEN-INDEPENDENT HUMAN AND RAT PROSTATE CARCINOMA CELL-LINES, Cancer letters, 70(3), 1993, pp. 159-166
Prostatic inhibin peptide (PIP), consisting of 94 amino-acid residues
is synthesized and secreted by the prostate gland. Previous studies on
immunohistochemical localization of PIP in primary prostatic tumor an
d their metastasis, have documented the value of this peptide as a tum
or marker for diagnosis of prostate cancer (PCa). The present study wa
s undertaken to compare the expression of PIP with that of prostate sp
ecific antigen (PSA) and prostatic acid phosphatase (PAP) in androgen
independent human PCa cell lines (PC-3, DU-145 and TSU-Prl) by immunop
eroxidase technique. The results of the study indicated that the stain
ing for PIP was more intense than that of PSA and PAP. The PSA stainin
g was either weakly positive (PC-3) or totally absent (TSU-Prl and DU-
145) while PAP staining was intense in PC-3 and moderate in the other
two human cell lines. The intense staining observed for PIP in all of
the androgen independent cell lines suggests that the synthesis and se
cretion of PIP is not primarily dependent on androgens. Furthermore, e
xpression of these markers in Dunning rat,cultured adenocarcinoma cell
lines and tumors were studied. Positive staining for all three human
tumor associated antigens (PIP, PSA and PAP) cross-reacting with the D
unning rat PCa cell lines and the tumors, suggest the suitability of t
his model for preclinical screening of various therapeutic agents.